Brief: New Nordic Healthbrands Q4 EBITDA Roughly Stable At SEK 10.0 Mln

New Nordic Healthbrands AB

01/03/2019 07:05

March 1 (Reuters) - New Nordic Healthbrands AB  NWND.ST :
    * Q4 NET SALES AMOUNTED TO MSEK 97.6 (86.6), AN INCREASE OF
12.7
PERCENT
    * Q4 EBITDA SEK 10.0 MILLION VERSUS SEK 9.9 MILLION YEAR AGO
    * Q4 EBITDA INCREASED TO MSEK 10.0 (9.9).
    * Q4 PROFIT AFTER TAX FOR PERIOD INCREASED TO MSEK 7.2 (6.6)
    * Q4 PROFIT AFTER TAX FOR PERIOD INCREASED TO MSEK 7.2
(6.6).
    * "I LOOK FORWARD TO AN EVENTFUL AND SUCCESSFUL YEAR IN
2019" -
CEO
    * SAYS OUR EFFORTS REDUCED POSITIVE PROFIT CONTRIBUTION IN
US IN
2018 BUT EXPECT TO SEE EFFECT AS EARLY AS 2019
    * DECIDED TO PROPOSE A DIVIDEND OF SEK 1.50 PER SHARE (1.15)
TO
THE ANNUAL GENERAL MEETING

Source text for Eikon:  ID:nBQN9dLvS6 
Further company coverage:  NWND.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))